Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07606469 · ClinicalTrials.gov registry record
Human Neural Correlates of Multi-Timescale Inference
A clinical trial, sponsored by University of Colorado, Boulder.
- Not yet
- Registry status
- 30
- Enrollment target
NCT07606469: Clinical Trial study, sponsored by University of Colorado, Boulder.
NCT07606469 is a clinical trial that has not yet begun recruiting, run by University of Colorado, Boulder. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07606469 has not yet begun recruiting, sponsored by University of Colorado, Boulder.
- NOT YET RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
Adult epilepsy patients who are undergoing intracranial monitoring will participate in a simple behavioral task during the clinical recording period.
Primary Outcome
pupil size will be measured with a portable eye-tracking device and correlated with task features
Interventions
- BEHAVIORAL Decision-making task
- BEHAVIORAL eye tracking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2028-06-30 |
What is known before NCT07606469 opens enrollment
NCT07606469 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Decision-making task is the first listed.
NCT07606469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07606469 about?
NCT07606469 is a clinical study titled "Human Neural Correlates of Multi-Timescale Inference". Adult epilepsy patients who are undergoing intracranial monitoring will participate in a simple behavioral task during the clinical recording period.
What is the current status of trial NCT07606469?
This trial is currently not yet recruiting. The enrollment target is 30 participants. The study started on 2026-06-15. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07606469?
The interventions under investigation include: Decision-making task (BEHAVIORAL), eye tracking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07606469?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI